Zhenyu Xu
Chief Scientific Officer · SOPHiA GENETICS SA
IndividualSelling only28 10b5-1 trades
- 2026
- Oct 7, 2026
- 19
Filings (90d)
7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Zhenyu Xu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jurgi Camblong - $2.65M in SOPH purchases and sales in the last 12 months
- Philippe Menu - $478K in SOPH purchases and sales in the last 12 months
- Abhimanyu Verma - $266K in SOPH purchases and sales in the last 12 months
- Ross Muken - $225K in SOPH purchases and sales in the last 12 months
- Manuela Valente - $159K in SOPH purchases and sales in the last 12 months
- Well Daan van - $142K in SOPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Zhenyu Xu?
Zhenyu Xu is a corporate insider, tracked as Chief Scientific Officer of SOPHiA GENETICS SA (SOPH). InsiderAlpha holds 19 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Zhenyu Xu submitted recently?
7 primary Form 4 filings in the last 90 days, covering 1 company.
Has Zhenyu Xu been buying or selling stock?
Recorded transactions: 0 open-market purchases and 24 open-market sales ($761K) across all tracked filings.
